Total Payments
$2,350
2020 Payments
$77.58
Companies
10
Transactions
90
Medicare Patients
394
Medicare Billing
$67,300
Payment Breakdown by Category
Food & Beverage$2,350 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,350 | 90 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,012 | 47 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $668.06 | 22 | $0 (2020) |
| PFIZER INC. | $476.60 | 11 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $65.48 | 3 | $0 (2018) |
| Kaleo, Inc. | $32.00 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $22.26 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $22.22 | 1 | $0 (2018) |
| Genentech USA, Inc. | $21.67 | 1 | $0 (2018) |
| Circassia Pharmaceuticals Inc | $16.70 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $13.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $77.58 | 3 | AstraZeneca Pharmaceuticals LP ($37.68) |
| 2019 | $176.00 | 2 | GlaxoSmithKline, LLC. ($125.00) |
| 2018 | $1,039 | 42 | GlaxoSmithKline, LLC. ($432.77) |
| 2017 | $1,057 | 43 | GlaxoSmithKline, LLC. ($436.61) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2020 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Respiratory | ||||||
| 02/05/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $37.68 | General |
| 10/22/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $51.00 | General |
| 11/20/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/26/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $123.05 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/19/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 06/12/2018 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), DULERA | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Respiratory | ||||||
| 06/05/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 05/22/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/22/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: DERMATOLOGY | ||||||
| 05/10/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Respiratory | ||||||
| 05/03/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 24 | 25 | $7,500 | $1,400 |
| 2021 | 8 | 190 | 466 | $116,950 | $39,250 |
| 2020 | 8 | 180 | 445 | $104,325 | $26,650 |
Total Patients
394
Total Services
936
Medicare Billing
$67,300
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $7,500 | $1,400 | 18.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 212 | $63,600 | $25,281 | 39.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 92 | $23,000 | $7,316 | 31.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $12,000 | $3,328 | 27.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 17 | 17 | $3,850 | $1,129 | 29.3% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 11 | 25 | $3,125 | $1,035 | 33.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 16 | 22 | $4,400 | $655.38 | 14.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $1,375 | $366.84 | 26.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 19 | 56 | $5,600 | $138.50 | 2.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 209 | $52,250 | $13,500 | 25.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 67 | $20,100 | $6,953 | 34.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $12,000 | $3,389 | 28.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 14 | 14 | $2,800 | $853.72 | 30.5% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 21 | 33 | $6,600 | $755.50 | 11.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 16 | $2,800 | $720.00 | 25.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $1,275 | $316.00 | 24.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2020 | 17 | 65 | $6,500 | $162.40 | 2.5% |
About Dr. Ellen Epstein, MD
Dr. Ellen Epstein, MD is a Allergy & Immunology healthcare provider based in Rockville Centre, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447215363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellen Epstein, MD has received a total of $2,350 in payments from pharmaceutical and medical device companies, with $77.58 received in 2020. These payments were reported across 90 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,350).
As a Medicare-enrolled provider, Epstein has provided services to 394 Medicare beneficiaries, totaling 936 services with total Medicare billing of $67,300. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Rockville Centre, NY
- Active Since 04/20/2006
- Last Updated 10/16/2007
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447215363
Products in Payments
- BREO (Drug) $611.46
- EUCRISA (Drug) $476.60
- NUCALA (Biological) $382.92
- SYMBICORT (Drug) $308.50
- FASENRA (Drug) $146.18
- DUPIXENT DUPILUMAB INJECTION (Biological) $65.48
- Auvi-Q (Drug) $32.00
- AirDuo Digihaler (Drug) $22.26
- XOLAIR (Biological) $22.22
- Xolair (Biological) $21.67
- TRELEGY ELLIPTA (Drug) $17.64
- TUDORZA PRESSAIR (Drug) $16.70
- ASMANEX (Drug) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.